At PersonaDx, we are reshaping cancer care through molecular genetics and AI-driven clinical risk assessment. Our innovative platform revolutionizes oncology with unmatched 96% accuracy in colorectal tumor classification, informing metastatic cancer prognosis and delivering personalized treatment solutions to improve patient outcomes and overall quality of life.
The only clinically validated, metastasis-specific biomarker:
PersonaDx addresses metastatic colorectal cancer (CRC) with the first and only test of its kind.
96% accuracy:
Revolutionizing prognostic precision with neural network validation.
Risk-based stratification:
Stratifies patients into risk groups by integrating disease biology with clinical data.
Improved outcomes:
Avoids unnecessary treatments, reduces costs, and enhances overall survival rates.
Validated in clinical trials:
Supported by Phase 3 New-EPOC trial results for proven success.
Comprehensive molecular insights:
Offers both 31-gene (mRNA and microRNA) and 150-gene (mRNA only) biomarker assays adaptable to various sequencing platforms, providing actionable data for personalized care.
Focused on patient impact:
Designed for patients with colorectal cancer metastases confined to the liver, enabling better-informed therapy decisions for improved survival and potential cure.
Discover the full details of how PersonaDx can enhance personalized care and improve outcomes.
For comprehensive information about this groundbreaking test, or to schedule a meeting to discuss our tests with Leadership, send an email to: ✉️ info@persona-dx.com
Company Details
- Employees
- 3
- Founded
- -
- Address
- 600 W Jackson Blvd, Chicago,illinois 60661,united States
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://persona-dx.com
- Keywords
- Metastatic Cancer, Diagnosis, Radiotherapy, Immunotherapy, Cancer, Biotechnology, Genetic Sequencing, AI-Powered Cancer Prognosis, Cancer Prognosis, Metastatic Cancer Prognosis, Precision Medicine, Personalized Medicine, Personalized Cancer Prognosis, Precision Oncology, Metastatic Tumor, Genomic Sequencing, Precision Oncology Solutions, AI-Driven Cancer Diagnostics, Personalized Metastatic Cancer Prognosis, Advanced Molecular Genetics in Cancer Care, AI-Driven Cancer Diagnostics, High-Accuracy Cancer Prognosis, Pharmaceutical Partnerships in Oncology, Targeted Cancer Therapy Insights, AI Integration in Cancer Research.
- HQ
- Chicago, Illinois
Personadx Questions
Personadx's website is http://persona-dx.com
Personadx's LinkedIn profile is https://www.linkedin.com/company/personadx
Personadx has
3 employees.
View email and phone details for 3
employees at Personadx.
Personadx's industry is
Hospitals and Health Care
Personadx's top competitors are
Motley Bio,
Misogi Labs,
Xuron,
The Phillips Group Oncology Communications,
Syzonc,
Recode Ventures,
Atom Bioworks,
Orgagen Biosciences,
Augment Biologics,
Orbits Oncology.
Personadx's categories are Hospitals and Health Care
Personadx's founding year is 2022
